Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

FDA medical devices advisory committee to meet today

Dec. 20, 1996

Knoll licenses technology for use in cardiovascular research

Dec. 19, 1996

New lipophilic drug delivery agents from Scotia

Dec. 19, 1996

Inactivation of SIV by LifeTECH's blood sterilization technology

Dec. 17, 1996

Celox Laboratories' ViaStem receives patent coverage

Dec. 16, 1996

Epic receives patent coverage for core drug delivery technology

Dec. 16, 1996

Terrapin Technologies obtains rights to Walter Reed compound library

Dec. 16, 1996

Visible Genetics acquires BIOS Laboratories technology

Dec. 13, 1996

Myriad Genetics announces research collaboration

Dec. 13, 1996

CEPRATE SC approved for marketing in U.S.

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...